Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer

被引：0
|
作者：
Danyang Sun
Junxun Ma
Jinliang Wang
Chun Han
Yuanyu Qian
Guangying Chen
Xiaoyan Li
Juan Zhang
Pengfei Cui
Wushuang Du
Zhaozhen Wu
Shixue Chen
Xuan Zheng
Zhichao Yue
Jia Song
Chan Gao
Xiaochen Zhao
Shangli Cai
Yi Hu
机构：
[1] Chinese People’s Liberation Army General Hospital,Department of Medical Oncology
[2] 3D Medicines Inc.,The Medical Department
来源：
Cancer Immunology, Immunotherapy | 2019年 / 68卷
关键词：
Biliary tract cancer; PD-1 inhibitors; Combination therapy; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1527 / 1535
页数：8
相关论文
共 50 条
  • [1] Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer
    Sun, Danyang
    Ma, Junxun
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Gao, Chan
    Zhao, Xiaochen
    Cai, Shangli
    Hu, Yi
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (09) : 1527 - 1535
  • [2] A retrospective cohort study of anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer.
    Sun, Danyang
    Ma, Junxun
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Zhao, Xiaochen
    Cai, Shangli
    Hu, Yi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Anti-PD-1 therapy combined with chemotherapy or target therapy in patients with advanced biliary tract cancer in real-world clinical setting
    Sun, D.
    Ma, J.
    Han, C.
    Wang, J.
    Qian, Y.
    Chen, G.
    Li, X.
    Zhang, J.
    Song, J.
    Zhao, X.
    Cai, S.
    Hu, Y.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 437 - 437
  • [4] Blood tests predict the therapeutic prognosis of anti-PD-1 in advanced biliary tract cancer
    Du, Fei
    Qiu, Zhiquan
    Ai, Wenchao
    Huang, Chenjun
    Ji, Jun
    Xiao, Xiao
    Zhou, Jun
    Fang, Meng
    Jiang, Xiaoqing
    Gao, Chunfang
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2021, 110 (02) : 327 - 334
  • [5] Anti-PD-1 therapy combined with chemotherapy in patients with advanced pancreas cancer in a real-world clinical setting.
    Sun, Danyang
    Ma, Junxun
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Cai, Shangli
    Hu, Yi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Anti-PD-1 combination regimen as first-line therapy in advanced biliary tract cancer and biomarker exploration: A retrospective study
    Guo, Jingyi
    Zhou, Qun
    Zhou, Mingzhen
    Dai, Hengheng
    Li, Lin
    Liu, Baorui
    Shen, Jie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?
    Klein, Oliver
    Kee, Damien
    Nagrial, Adnan
    Markman, Ben
    Underhill, Craig
    Michael, Michael
    Behren, Andreas
    Palmer, Jodie
    Tebbutt, Niall C. C.
    Carlino, Matteo S. S.
    Cebon, Jonathan
    [J]. CANCER, 2023, 129 (07) : 1129 - 1130
  • [8] Chemotherapy combined with targeted therapy and immunotherapy is an option in advanced biliary tract cancer
    Ge, Penglei
    Wu, Yang
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [9] Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancers
    An, Tianqi
    Hui, Qiu
    Zong, Hong
    Liu, Linhua
    Cao, Xinguang
    Li, Rui
    Hu, Shuang
    Liu, Yiyi
    Li, Jia
    Zhao, Ruihua
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (07): : 1647 - 1663
  • [10] Experience With Anti-PD-1 Antibody, Camrelizumab, Monotherapy for Biliary Tract Cancer Patients and Literature Review
    Shen, Tian
    Zheng, Shanhua
    Geng, Lei
    Liu, Zhengtao
    Xu, Jun
    Lin, Bingyi
    Qian, Junjie
    Zheng, Shusen
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
12345